Sotera Health Company (SHC)
NASDAQ • Healthcare
Last close at September 22, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Sotera Health Company keeps $17 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 41 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Sotera Health beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 6, 2026, with adjusted EPS of $0.26 topping the $0.24 estimate (+9%) as revenue of $321.4 million topped the $309.7 million estimate (+3.8%). Revenue rose ~9% to about $321.4 million (up from roughly $294.3 million a year ago), supported by its sterilization, laboratory testing, and advisory services for regulated product makers. Profitability ran at a gross margin of roughly 55% and an operating margin near 33%, with gross profit of about $178.0 million and operating income of roughly $106.8 million. Net income jumped ~574% to about $53.6 million, up from roughly $8.0 million a year ago, while adjusted EPS rose 30% from $0.20. The company generated about $88.5 million in operating cash flow during the quarter. For the next period, consensus calls for EPS of $0.27 on revenue of $319.8 million.
About Sotera Health Company
Sotera Health Company trades on the NASDAQ under SHC and operates in healthcare through sterilization services, laboratory testing services, and advisory work for regulated product makers. The company generated $1.2 billion of revenue in FY2025 and sits within the medical diagnostics and research business.
Today's Snapshot
The day ended with SHC slightly lower at 18.69, while its sector was firmer. Shares changed hands at about two-thirds of its usual level.
Trading Volume
Below 10d avg (2.3M)
1.4M
vs S&P 500 Today
Moderate Underperformance
-0.19%
Updated: September 22, 2026 at 20:16 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$17.24 - $18.78Buy
- RSI (14)49.15Neutral
- Stochastic %K (14, 3, 3)42.74Neutral
- MACD Level (12, 26)0.04Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.